Closing the Post-TAVR Care Gap

Transcatheter aortic valve replacement has transformed the treatment of aortic stenosis. Procedural success rates are high, and early mortality has declined significantly. But a successful valve replacement doesn't guarantee a successful recovery — and the data on what happens after discharge tells a more complicated story than the procedure itself.

The valve gets fixed. The risk doesn't disappear.

More than one in five TAVR patients experience a heart failure hospitalization within a year. Roughly two-thirds of deaths in this population are non-cardiac, driven by infection and systemic decline that standard post-discharge care isn't built to catch. The patient becomes clinically invisible the moment they walk out of the hospital — that's the actual problem.

SYNC-PREVENT™ closes that gap by transitioning every TAVR patient — not just the ones who already look high-risk — into continuous monitoring at discharge. Hemodynamic monitoring establishes a baseline filling pressure and gives the physician a read on residual congestion. An ECG patch covers rhythm monitoring for the first 30 days, followed by intermittent monitoring through day 90. Weight, blood pressure, heart rate, and oxygen readings — tracked against parameters the ordering physician defines — put the early signs in front of the care team roughly one to two weeks before they'd otherwise appear.

Two signals for infection, not one

Across the first 60 days — the window where sepsis and systemic decline do the most damage and get watched the least — structured temperature measurement data is collected and transmitted for physician review, alongside physician-ordered biomarker testing. Temperature trend data supports the treating physician's ongoing clinical assessment of patient status during the post-operative monitoring period, and a composite index calculated from the labs (hs-CRP, serum albumin, lymphocyte count) is presented to the ordering physician for review — drawn from labs many patients are already having, with no additional testing required to generate it.

“This is the part that matters most: two independent data streams for the physician's infection-risk assessment — structured device-based temperature measurement and provider-ordered biomarker testing — instead of relying on either one alone.”

The interoperability layer also pulls the discharging physician's summary directly into the monitoring record, closing the medication-reconciliation gap that drives a meaningful share of post-procedure readmissions. TAVR solves the valve. What happens in the following ninety days is what SYNC-PREVENT™ is built to watch.